Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 12 recruiting now later-stage tilt

Kidney Transplant; Complications: later-stage trial registry

12 of 20 indexed Kidney Transplant; Complications trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #848 of 28,707 conditions by registered trial count.

20 US clinical trials · 12 currently recruiting · #848 of 28,707 conditions by registered trial count

Kidney Transplant; Complications: 20 US clinical trials tracked, 12 recruiting.

Kidney Transplant; Complications is the subject of 20 registered US clinical trials on ClinicalTrials.gov, 12 of them currently open to new participants. 8 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Virginia Commonwealth University, running 3 of these trials.

Enrollment posture brief

Registry condition kidney-transplant-complications

OPEN 12 | RECR 60% | LATE 8 | EARLY 4 | RANK #848 | SPON 3

Nearest open-share peer: Abuse, Drug (60% recruiting · 5 trials)

Kidney Transplant; Compl (th…60%Advanced or Metastatic Solid55%ALS50%Abdominal Pain25%Acute Myocardial Infarction25%
Open-enrollment share among volume-matched conditions near Kidney Transplant; Complications

Kidney Transplant; Complications lists 12 open slots (60% of 20 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Kidney Transplant; Complications on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Kidney Transplant; Complications is recruiting above its size-band peers.

    12 of 20 indexed trials (60%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Kidney Transplant; Complications research.

    Virginia Commonwealth University accounts for 3 of 20 trials (15%). 14 distinct sponsors appear on at least one study for this condition label.

  3. Most Kidney Transplant; Complications trials plan to enrol fewer than 100 people.

    Median target enrolment is 80 among the 20 trials that report a genuine target (sentinel values excluded). 12 of those (60%) plan for fewer than 100 participants.

  4. Kidney Transplant; Complications research is mostly interventional.

    18 interventional and 2 observational studies make up this index (90% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 13Phase 21Phase 32Phase 46

Open and recent trials

20 total, page 1 of 1

RECRUITING NA 438 participants

Double Voiding and Post-transplant UTI

Weill Medical College of Cornell University

NCT05711446

RECRUITING Phase 3 360 participants

Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients

University of California, San Francisco

NCT06798909

RECRUITING Phase 2 150 participants

The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study

University of North Carolina, Chapel Hill

NCT06059664

RECRUITING NA 136 participants

Structured Program of Exercise for Recipients of Kidney Transplantation

University of California, San Francisco

NCT04954690

RECRUITING NA 120 participants

Dietary Intervention to Improve Kidney Transplant Outcomes

University of California, Davis

NCT05449496

RECRUITING Phase 4 120 participants

Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients

University of Colorado, Denver

NCT05005793

RECRUITING Phase 4 80 participants

Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients

University of Colorado, Denver

NCT06140537

RECRUITING Phase 4 80 participants

Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)

Camille N. Kotton, MD

NCT06958796

RECRUITING NA 80 participants

Use of CGM in Kidney Transplant Recipients

University of California, Davis

NCT04783441

RECRUITING 60 participants

Immune Registry for BK in Kidney Transplant Recipients

Virginia Commonwealth University

NCT06538961

RECRUITING NA 30 participants

Feasibility Study for the Comprehensive Overweight/Obesity Management Pre-Kidney Transplant (COMPKT) Program

Virginia Commonwealth University

NCT06688825

RECRUITING Phase 1 30 participants

CMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients

University of Minnesota

NCT07096453

ACTIVE NOT RECRUITING Phase 4 200 participants

A Study to Evaluate Preemptive Therapy in Hepatitis C (HCV) Organ Transplant Recipients

Mayo Clinic

NCT04508907

ACTIVE NOT RECRUITING 180 participants

Highly Suppressive Treg in Delayed and Slow Graft Function After Kidney Transplantation

St. Louis University

NCT04414111

ACTIVE NOT RECRUITING Phase 3 60 participants

De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Transplant Recipients

Virginia Commonwealth University

NCT06001320

ACTIVE NOT RECRUITING Phase 4 60 participants

Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney Transplants

Roy D. Bloom, MD

NCT03841097

ACTIVE NOT RECRUITING Phase 1 20 participants

Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant

Stanley Jordan, MD

NCT03380962

ACTIVE NOT RECRUITING Phase 1 20 participants

Delayed Tolerance Through Mixed Chimerism

Massachusetts General Hospital

NCT05900401

COMPLETED Phase 4 84 participants

Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade at the End of Kidney Transplantation Surgery

University of Colorado, Denver

NCT03923556

COMPLETED NA 8 participants

Evaluation and Management of Metabolic Bone Disease in Kidney Transplant Recipients

Yale University

NCT03958409

Phase Distribution

PhaseTrial count
Phase 1 3
Phase 2 1
Phase 3 2
Phase 4 6

Named interventions

Most-linked intervention names on Kidney Transplant; Complications records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
3 trials
standard care Diagnostic test
1 trials
measurements to evaluate metabolic bone disease Diagnostic test
1 trials
Peripheral Blood Stem Cell Collection Procedure
1 trials
Bone Marrow Transplant Other
1 trials
Mavyret Drug
1 trials
Immediate Release Tacrolimus Capsule Drug
1 trials
Extended Release Tacrolimus Tablets Drug
1 trials

US sites by state

Facility locations filed on Kidney Transplant; Complications trials. A trial with sites in several states counts in each.

California 6 trials
Virginia 4 trials
Colorado 3 trials
Massachusetts 2 trials
Texas 1 trials
Pennsylvania 1 trials
New York 1 trials
New Jersey 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Kidney Transplant; Complications page

20 registered trials, 12 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Kidney Transplant; Complications condition card totals 20 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.